ICE Is the New Face of America’s Legacy of Forced Sterilization
By Melissa Gira Grant,
The New Republic
| 09. 17. 2020
Earlier this week, multiple human rights organizations filed a complaint on behalf of women detained at an Immigration and Customs Enforcement facility in Georgia. Based on accounts from detainees and corroborated by a nurse who worked at the facility, the Irwin County Detention Center, the complaint alleges multiple examples of substandard medical care, particularly around coronavirus prevention and treatment. But what has drawn the most public outcry is allegations of what has been described as mass hysterectomies or sterilizations.
“When I met all these women who had had surgeries, I thought this was like an experimental concentration camp. It was like they’re experimenting with our bodies,” one detained immigrant told Project South, one of the groups who filed the complaint. She said she knew of five other women detained with her at ICDC who said they had undergone hysterectomies between October and December 2019. “I’ve had several inmates tell me that they’ve been to see the doctor and they’ve had hysterectomies and they don’t know why they went or why they’re going,” said Dawn Wooten, the nurse who worked...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...